Toxicological aspects for nanomaterial in humans

Methods in Molecular Biology

Volumn 948, Issue , 2013, Pages 1-12

  Dusinska, Maria ^a   Magdolenova, Zuzana ^a   Fjellsbø, Lise Marie ^a  

^a NORWEGIAN INSTITUTE FOR AIR RESEARCH   (Norway)

Author keywords

Hazard assessment; In vitro tests; In vivo tests; Mechanisms of toxicity; Nanomaterial safety; Uptake

Indexed keywords

NANOMATERIAL; NANOPARTICLE;

ARTICLE; CARCINOGENESIS; CYTOTOXICITY; ENVIRONMENTAL EXPOSURE; GENOTOXICITY; HAZARD ASSESSMENT; HUMAN; NANOTOXICOLOGY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SAFETY; STANDARD; TOXICITY TESTING; TRANSPORT KINETICS;

EID: 84934438441     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-140-0_1     Document Type: Article

References (67)

1. Donaldson K, Stone V, Tran CL et al (2004) Nanotoxicology. Occup Environ Med 61: 727-728
2. Haynes CL (2010) The emerging fi eld of nanotoxicology. Anal Bioanal Chem 398:587-588
3. Maynard AD, Warheit DB, Philbert MA (2011) The new toxicology of sophisticated materials: nanotoxicology and beyond. Toxicol Sci 120(Suppl 1):S109-S129
4. Kroll A, Pillukat MH, Hahn D et al (2009) Current in vitro methods in nanoparticle risk assessment: limitations and challenges. Eur J Pharm Biopharm 72:370-377
5. Feliu N, Fadeel B (2010) Nanotoxicology: no small matter. Nanoscale 2:2514-2520
6. Dusinska M, Fjellsbo L, Magdolenova Z et al (2009) Testing strategies for the safety of nanoparticles used in medical applications. Nanomedicine (Lond) 4:605-607
7. EMEA (2006) Re fl ection Paper on Nanotechnology-Based Medicinal Products for Human Use, EMEA/CHMP/79769/2006. www.emea.europa.eu/pdfs/human/genetherapy/ 7976906en.pdf
8. Gwinn MR, Tran L (2010) Risk management of nanomaterials. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2:130-137
9. Stone V, Nowack B, Baun A et al (2010) Nanomaterials for environmental studies: classi fi cation, reference material issues, and strategies for physico-chemical characterization. Sci Total Environ 408:1745-17454
10. Bouwmeester H, Lynch I, Marvin HJP et al (2011) Minimal analytical characterisation of engineered nanomaterials needed for hazard assessment in biological matrices. Nanotoxicology 5:1-11
11. Commitee ES (2011) Guidance on the risk assessment of the application of nanoscience and nanotechnologies in the food and feed chain. EFSA Journal 9:2140-2176
12. Faraji AH, Wipf P (2009) Nanoparticles in cellular drug delivery. Bioorg Med Chem 17:2950-2962
13. Warheit DB, Sayes CM, Reed KL et al (2008) Health effects related to nanoparticle exposures: environmental, health and safety considerations for assessing hazards and risks. Pharmacol Ther 120:35-42
14. Kunzmann A, Andersson B, Thurnherr T et al (2011) Toxicology of engineered nanomaterials: focus on biocompatibility, biodistribution and biodegradation. Biochim Biophys Acta 1810:361-373
15. Dhawan A, Sharma V (2010) Toxicity assessment of nanomaterials: methods and challenges. Anal Bioanal Chem 398:589-605
16. Borm PJ, Muller-Schulte D (2006) Nanoparticles in drug delivery and environmental exposure: same size, same risks? Nanomedicine (Lond) 1:235-249
17. Oberdorster G, Oberdorster E, Oberdorster J (2005) Nanotoxicology: an emerging discipline evolving from studies of ultra fi ne particles. Environ Health Perspect 113:823-839
18. Adiseshaiah PP, Hall JB, McNeil SE (2009) Nanomaterial standards for ef fi cacy and toxicity assessment. Nanotechnology 2:99-112
19. Goodman CM, McCusker CD, Yilmaz T et al (2004) Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. Bioconjug Chem 15:897-900
20. Kayat J, Gajbhiye V, Tekade RK et al (2011) Pulmonary toxicity of carbon nanotubes: a systematic report. Nanomedicine 7:40-49
21. Nel A (2005) Atmosphere air pollution-related illness: effects of particles. Science 308:804
22. Eom HJ, Choi J (2010) p38 MAPK activation, DNA damage, cell cycle arrest and apoptosis as mechanisms of toxicity of silver nanoparticles in Jurkat T cells. Environ Sci Technol 44:8337-8342
23. Hsin YH, Chen CF, Huang S et al (2008) The apoptotic effect of nanosilver is mediated by a ROS- and JNK-dependent mechanism involving the mitochondrial pathway in NIH3T3 cells. Toxicol Lett 179:130-139
24. Dailey LA, Jekel N, Fink L et al (2006) Investigation of proin fl ammatory potential of biodegradable nanoparticle drug delivery systems in the lung. Toxicol Appl Pharmacol 215:100-108
25. Magdolenova Z, Dhawan A, Collins A, Stone V, Dusinska M Mechanisms of Genotoxicity. A Review of Recent in vitro and in vivo Studies with Engineered Nanoparticles. Nanotoxicology. Submitted
26. Stone V, Johnston H, Schins RP (2009) Development of in vitro systems for nanotoxicology: methodological considerations. Crit Rev Toxicol 39:613-626
27. Singh N, Manshian B, Jenkins GJ et al (2009) NanoGenotoxicology: the DNA damaging potential of engineered nanomaterials. Biomaterials 30:3891-3914
28. Liang XJ, Chen C, Zhao Y et al (2008) Biopharmaceutics and therapeutic potential of engineered nanomaterials. Curr Drug Metab 9:697-709
29. Asharani PV, Low Kah Mun G, Hande MP et al (2009) Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano 3:279-290
30. Seaton A, Tran L, Aitken R et al (2010) Nanoparticles, human health hazard and regulation. J R Soc Interface 7(Suppl 1): S119-S129
31. Simko M, Mattsson MO (2010) Risks from accidental exposures to engineered nanoparticles and neurological health effects: a critical review. Part Fibre Toxicol 7:42
32. Oberdörster G, Maynard A, Donaldson K et al (2005) Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol 2:8
33. Abbott A (2003) Cell culture: biology's new dimension. Nature 424:870-872
34. Byrne H. J., Lynch I., de Jong W. H. et al. (2010) Protocols for assessment of biological hazards of engineered nanoparticles. European network on the health and environmental impact of nanomaterials, pp 1-30, http://www.nanoimpactnet. eu/uploads/fi le/Reports-Publications/D1. 7%20Protocols%20for%20Assessment%20 Bio-Hazards%20in%20ENMs.pdf
35. Priya BR, Byrne HJ (2008) Investigation of sodium dodecyl benzene sulphonate assisted dispersion and debundling of single wall carbon nanotubes. J Phys Chem C 112:332-337
36. Liu F, Soares MJ, Audus KL (1997) Permeability properties of monolayers of the human trophoblast cell line BeWo. Am J Physiol 273: C1596-C1604
37. Ampasavate C, Chandorkar GA, Vande Velde DG et al (2002) Transport and metabolism of opioid peptides across BeWo cells, an in vitro model of the placental barrier. Int J Pharm 233:85-98
38. Saunders M (2009) Transplacental transport of nanomaterials. Wiley Interdiscip Rev Nanomed Nanobiotechnol 1:671-684
39. Brown J, Reading SJ, Jones S et al (2000) Critical evaluation of ECV304 as a human endothelial cell model de fined by genetic analysis and functional responses: a comparison with the human bladder cancer derived epithelial cell line T24/83. Lab Invest 80:37-45
40. Saovapakhiran A, D'Emanuele A, Attwood D et al (2009) Surface modi fi cation of PAMAM dendrimers modulates the mechanism of cellular internalization. Bioconjug Chem 20:693-701
41. Herzog E, Casey A, Lyng FM et al (2007) A new approach to the toxicity testing of carbonbased nanomaterials-The clonogenic assay. Toxicol Lett 174:49-60
42. Ng CT, Li JJ, Bay BH et al (2010) Current studies into the genotoxic effects of nanomaterials. J Nucleic Acids pii:947859
43. Mortelmans K, Zeiger E (2000) The Ames Salmonella/microsome mutagenicity assay. Mutat Res 455:29-60
44. Landsiedel R, Kapp MD, Schulz M et al (2009) Genotoxicity investigations on nanomaterials: methods, preparation and characterization of test material, potential artifacts and limitations-many questions, some answers. Mutat Res 681:241-258
45. Shinohara N, Matsumoto K, Endoh S et al (2009) In vitro and in vivo genotoxicity tests on fullerene C60 nanoparticles. Toxicol Lett 191:289-296
46. Mori T, Takada H, Ito S et al (2006) Preclinical studies on safety of fullerene upon acute oral administration and evaluation for no mutagenesis. Toxicology 225:48-54
47. Wirnitzer U, Herbold B, Voetz M et al (2009) Studies on the in vitro genotoxicity of baytubes, agglomerates of engineered multi-walled carbon-nanotubes (MWCNT). Toxicol Lett 186:160-165
48. Di Sotto A, Chiaretti M, Carru GA et al (2009) Multi-walled carbon nanotubes: lack of mutagenic activity in the bacterial reverse mutation assay. Toxicol Lett 184:192-197
49. Balasubramanyam A, Sailaja N, Mahboob M et al (2010) In vitro mutagenicity assessment of aluminium oxide nanomaterials using the Salmonella/microsome assay. Toxicol In Vitro 24:1871-1876
50. Maenosono S, Suzuki T, Saita S (2007) Mutagenicity of water-soluble FePt nanoparticles in Ames test. J Toxicol Sci 32:575-579
51. Maenosono S, Yoshida R, Saita S (2009) Evaluation of genotoxicity of amine-Terminated water-dispersible FePt nanoparticles in the Ames test and in vitro chromosomal aberration test. J Toxicol Sci 34:349-354
52. Yoshida R, Kitamura D, Maenosono S (2009) Mutagenicity of water-soluble ZnO nanoparticles in Ames test. J Toxicol Sci 34:119-122
53. Collins AR, Dusinska M, Gedik CM et al (1996) Oxidative damage to DNA: do we have a reliable biomarker? Environ Health Perspect 104(Suppl 3):465-469
54. Dusinska M, Collins AR (1996) Detection of oxidised purines and UV-induced photoproducts in DNA, by inclusion of lesion-speci fi c enzymes in the comet assay (single cell gel electrophoresis). ATLA 24:405-411
55. Jha AN (2008) Ecotoxicological applications and signi fi cance of the comet assay. Mutagenesis 23:207-221
56. O.E.C.D. (1997) Guidelines for testing chemicals. Mammalian erythrocyte micronucleus test. Vol. Guideline 474, Adopted: 21st July 1997, pp 1-10, http://www.oecd.org/chemicalsafety/assessmentofchemicals/1948442.pdf
57. Fenech M (2007) Cytokinesis-block micronucleus cytome assay. Nat Protoc 2: 1084-1104
58. Laingam S, Froscio SM, Humpage AR (2008) Flow-cytometric analysis of in vitro micronucleus formation: comparative studies with WIL2-NS human lymphoblastoid and L5178Y mouse lymphoma cell lines. Mutat Res 656:19-26
59. Fenech M, Kirsch-Volders M, Natarajan AT et al (2011) Molecular mechanisms of micronucleus, nucleoplasmic bridge and nuclear bud formation in mammalian and human cells. Mutagenesis 26:125-132
60. Gonzalez L, Sanderson BJ, Kirsch-Volders M (2011) Adaptations of the in vitro MN assay for the genotoxicity assessment of nanomaterials. Mutagenesis 26:185-191
61. Doak SH, Grif fi ths SM, Manshian B et al (2009) Confounding experimental considerations in nanogenotoxicology. Mutagenesis 24:285-293
62. Hackenberg S, Scherzed A, Kessler M et al (2011) Silver nanoparticles: evaluation of DNA damage, toxicity and functional impairment in human mesenchymal stem cells. Toxicol Lett 201:27-33
63. Galloway SM, Aardema MJ, Ishidate M Jr et al (1994) Report from working group on in vitro tests for chromosomal aberrations. Mutat Res 312:241-261
64. Galloway SM, Armstrong MJ, Reuben C et al (1987) Chromosome aberrations and sister chromatid exchanges in Chinese hamster ovary cells: evaluations of 108 chemicals. Environ Mol Mutagen 10(Suppl 10):1-175
65. Benigni R, Bossa C (2011) Alternative strategies for carcinogenicity assessment: an efficient and simpli fi ed approach based on in vitro mutagenicity and cell transformation assays. Mutagenesis 26:455-460
66. Clift MJ, Gehr P, Rothen-Rutishauser B (2011) Nanotoxicology: a perspective and discussion of whether or not in vitro testing is a valid alternative. Arch Toxicol 85: 723-731
67. Fischer HC, Chan WC (2007) Nanotoxicity: the growing need for in vivo study. Curr Opin Biotechnol 18:565-571